Cannabis News
Is the Marijuana Industry Just Like Big Tobacco in the 1950s?
Published
11 months agoon
By
admin
Is “Big Marijuana” really a thing, and is it Tobacco 2.0?
Personal experience powerfully programs our perspectives, often limiting objectivity on complex issues through confirmation bias. We unconsciously cherry-pick validating data to sustain internal narratives while ignoring contradictions causing cognitive dissonance.
This neurobiology explains the enduring futility of debates – discussing subjective qualia comparing limitless inner universes often devolves into discord. Belief calcifies position.
Nowhere does this play out more clearly than drugs policy discourse. The same statistics yield entirely conflicting conclusions depending on interpreter bias. Dry data morphs malleably serving agenda.
Hence in assessing perspectives, understanding personal incentives illuminating stance helps contextualizing arguments. Rather than debating interpretations, discern integrity of interpretation.
With this spirit of seeking higher truth, today we will critique a medical doctor’s opinion column opposing cannabis normalization by spotlighting recreational regulations ignoring public health.
While raising valid ethical points from his premise, prohibitionist assumptions negate discussing drug policy objectively. So we must evaluate lens rather than conclusions. Therein wisdom unfolds.
By illuminating inability seeing beyond bias, perhaps improved collective understanding emerges. The plants beckon beyond politicized rhetoric towards rooted truth.
His doctor rails against the public health impacts of for-profit recreational cannabis markets adopting predatory corporate tactics akin to 20th century’s tobacco industry playbook. Let’s examine his main points:
-
America moves rapidly toward nationwide legal access, yet regulations prioritize commercial interests over public welfare through lobbying, resembling alcohol and tobacco corruption escaping responsibility for widespread addiction and death previously.
-
The burgeoning cannabis industry now utilizes similar manipulative marketing ploys to expand usage, manufacturing consent bypassing ethical considerations. Tactics include misleading health benefit claims, relentlessly pushing ever-higher potency products, deceptive advertising masked as public education, regalia attracting youth, and aggravating mental illness risks.
-
Spiraling innovation manifests constantly new high-inducingforms like waxes, mints and lubricants for intensifying addictive dependencies. Lack of safety vetting or dosing consistency regulation raises acute toxicity and long-term medical complication possibilities resembling disastrous pharmaceutical epidemics but for a far less studied compound.
-
Massive corporate consolidation mirrors Big Tobacco’s profiteering playbook, extracting every advantage by hooking customers then denying culpability for destruction left in business model wake. Yet beyond marketing, true production costs for cannabis approximate pennies on retail’s dollar. This imminent nuevo-capitalist behemoth must face checks before morphing monstrous.
In summary, this doctor foresees public health calamity looming as cash-hungry cannabis commodifies previously safeguarded cognitive territories through influences impossible walking back once normalized, however convincing initial free market arguments. Just witness opioid tragedies. Hence the doctor advocates regulating cannabis under tobacco rather than alcohol policy to place health before wealth.
While clearly written in good faith out of genuine care for people’s welfare, glaring logical leaps beg addressing towards fully understanding all factors at play. Now we explore deeper…
While this doctor raises thoughtful concerns warranting discussion, several glaring logic leaps require addressing. Most problematic, none of the supposed public health threats named materialized so far where adult-use laws passed, making the dire forecasts speculative fiction. Real data soundly refutes assumptions.
Firstly, the cannabis industry operates nothing like predatory pharmaceutical tactics – if anything, persistent stigmatization and disproportionate taxation makes running sustainable ethical businesses challenging against illicit markets dancing regulatory obstacles. Idea of vulnerable minds preyed upon by suited cannabusinessmen ignores on-the-ground realities.
Equally faulty, the doctor ambiguates all marketing as insidious manipulation rather than below-the-line brand differentiation natural for any competitive sector. Silly to suggest every label makes health claims or targets kids. Reasonable regulations already govern most jurisdictions successfully. This is commerce, not coercion.
Also, the increased concentrate potency argument ignores consumer demand driving innovation. Equating higher THC levels with deadlier drugs contradicts science. Responsible personal liberty means informed adults freely modulating experiences, not universal standard dosing. Most eschew highest potencies after experimentation. Mortality remains nonexistent despite specters raised.
Next comparing cannabis to tobacco’s generational carnage ignores profound differences – smoking introduces combustion carcinogens where little exist ingesting otherwise. Meanwhile tobacco lacks cannabis’ extensive neuroprotective and wellness utilities backed by data. Conflating both plants under “smoke” epitomizes laziness serving narrative. Education counters alarmism.
Most concerning, suggesting quasi-prohibitionist strictures around packaging, retail density, home delivery etc overlooks the stubborn perseverance of legacy criminal elements without legal market competitiveness. Implementing high friction against fledgling businesses directly gifts the illicit industry enduring enterprise share while stymying access.
If public health prioritizes stopping lethal bleeding like fentanyl infiltration, tightly controlling cannabis proves exactly wrong tack. Keeping cultivation local sustains quality and origins. Unfortunately old models die hardest, especially when steeped in reefer madness goggles. But the doctor’s heart stays true if misled.
While public health arguments deserve airing to avoid policy pitfalls, we must acknowledge the outsized influence of doctors in shaping drug perceptions despite firsthand blind spots. This prohibitionist op-ed typifies clinical cannabis commentary cross-eyed by reefer madness precedent not data. And the public deserves our most informed opinions, not residual bias.
Conflating cannabis with far cruder intoxicants ignores profound differences in effects and mortality due to unique chemistry mods unseen elsewhere. Equally listing tobacco ignores not only combustion byproduct discrepancy but null medical utility contrasting cannabis’ extensive research confirming wellness benefits. This sloppy categorization serves agenda more than truth.
If any drug warrants such generous assessment, cannabis proves quintessential. Beyond constituent complexity and synaptic modulation, recorded use over millennia established unparalleled cultural ritual tradition and safety no other compound approaches. These layered nuances demand appropriately customized regulations aligning commerce pragmatics with community health.
Blanket prohibitions historically breed catastrophe through surrendering control authority cannot reclaim. Realities rule over idealism. Hence wise policy navigates human nature’s inevitability seeking altered states while channeling impulses towards responsibility, not demonization. Just results place people’s welfare before optics. But change takes courage commodified systems lack incentive supporting.
Doctors afraid of their own shadows in this arena require deeper introspection regarding irrational hesitancies delaying compassionate change. Because beyond branding bogeymen, the public recognizes fear itself fuels Contradiction most preventing reconciling cannabis fully into legal normalcy ultimately benefiting all. What resistance truly roots below denial against accepting higher paths?
IS CANNABIS BIG TOBACCO 2.0? READ ON..
You may like
-
Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em
-
I Had Just One Puff
-
Marijuana firms Eaze, Green Dragon find new life after $10 million capital infusion
-
Get some rest on Modified Grapes—November’s Leafly HighLight
-
Is Kratom Addictive? Understanding Dependence, Risks, and Safe Usage
-
New Rule, December 5: Oregon Cannabis Retailers, Processors and Labor Peace Agreements
Cannabis News
Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em
Published
19 hours agoon
November 13, 2024By
admin
On Thursday, November 7th, Vince Sliwoski, Aaron Pelley and Fred Rocafort held a post election discussion “Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em”. Watch the replay!
Key Takeaways from the “Smoke ’em if You’ve Got ’em – 2024 Post Election Cannabis Wrap” Webinar:
- Panelists:
- Vince Sliwoski: Oregon Business lawyer specializing in cannabis and commercial real estate.
- Aaron Pelley: Experienced in cannabis law since Washington’s legalization in 2012.
- Fred Rocafort: Trademark attorney working closely with the cannabis team.
- Election Results Overview:
- Most 2024 cannabis ballot measures did not pass.
- Florida, South Dakota, and North Dakota saw failures.
- Nebraska became the 39th state to legalize cannabis for medical use when it passed two cannabis initiatives, Initiatives 437 and 438.
- Federal and State-Level Developments:
- Medical use is currently legal in 38 states, and 24 states allow recreational use.
- Republican support for marijuana legalization is growing.
- Federal Policy Implications:
- Schedule III Rescheduling: The process to move cannabis to Schedule III is ongoing, which could significantly impact the industry.
- Importance of Federal Appointments: The future of cannabis policy depends heavily on who is appointed to key positions in the administration.
- International and Domestic Trade:
- Schedule III status could ease import/export restrictions on cannabis.
- Unified control of House, Senate, and presidency might expedite legislative progress.
- Economic and Industry Impact:
- Cannabis stocks experienced volatility post-election, reflecting investor uncertainty.
- Federal legalization and banking reforms are crucial for industry stability and growth.
- Future Outlook:
- The potential for federal rescheduling remains strong, with hearings scheduled for early 2025.
- State-level initiatives and regulatory developments will continue to shape the industry.
“How Long Does One Puff of Weed Stay in Your System?”… This topic can be difficult to answer since it is dependent on elements such as the size of the hit and what constitutes a “one hit.” If you take a large bong pull then cough, it might linger in your system for 5-7 days. A moderate dose from a joint can last 3-5 days, whereas a few hits from a vaporizer may last 1-3 days.
The length of time that marijuana stays in the body varies based on a number of factors, including metabolism, THC levels, frequency of use, and hydration.
Delta-9-tetrahydrocannabinol, or THC, is the primary psychoactive component of cannabis. THC and its metabolites, which remain in your body long after the effects have subsided, are detected by drug tests.
Since these metabolites are fat-soluble, they cling to bodily fat molecules. They could thus take a while to fully pass through your system, particularly if your body fat percentage is higher.
THC is absorbed by tissues and organs (including the brain, heart, and fat) and converted by the liver into chemicals such as 11-hydroxy-THC and carboxy-THC. Cannabis is eliminated in feces at a rate of around 65%, while urine accounts for 20%. The leftover amount might be kept within the body.
THC deposited in bodily tissues ultimately re-enters the circulation and is processed by the liver. For frequent users, THC accumulates in fatty tissues quicker than it can be removed, thus it may be detectable in drug tests for days or weeks following consumption.
The detection time varies according to the amount and frequency of cannabis usage. Higher dosages and regular usage result in longer detection times.
The type of drug test also affects detection windows. Blood and saliva tests typically detect cannabis metabolites for shorter periods, while urine and hair samples can reveal use for weeks or even months. In some cases, hair tests have detected cannabis use over 90 days after consumption.
Detection Windows for Various Cannabis Drug Tests
Urine Tests
Among all drug tests, urine testing is the most commonly used method for screening for drug use in an individual.
Detection times vary, but a 2017 review suggests the following windows for cannabis in urine after last use:
– Single-use (e.g., one joint): up to 3 days
– Moderate use (around 4 times a week): 5–7 days
– Chronic use (daily): 10–15 days
– Chronic heavy use (multiple times daily): over 30 days
Blood Tests
Blood tests generally detect recent cannabis use, typically within 2–12 hours after consumption. However, in cases of heavy use, cannabis has been detected up to 30 days later. Chronic heavy use can extend the detection period in the bloodstream.
Saliva Tests
THC can enter saliva through secondhand cannabis smoke, but THC metabolites are only present if you’ve personally smoked or ingested cannabis.
Saliva testing has a short detection window and can sometimes identify cannabis use on the same day. A 2020 review found that THC was detectable in the saliva of frequent users for up to 72 hours after use, and it may remain in saliva longer than in blood following recent use.
In areas where cannabis is illegal, saliva testing is often used for roadside screenings.
Hair Tests
Hair follicle tests can detect cannabis use for up to 90 days. After use, cannabinoids reach the hair follicles through small blood vessels and from sebum and sweat surrounding the hair.
Hair grows at approximately 0.5 inches per month, so a 1.5-inch segment of hair close to the scalp can reveal cannabis use over the past three months.
Factors Affecting THC and Metabolite Retention
The length of time THC and its metabolites stay in your system depends on various factors. Some, like body mass index (BMI) and metabolic rate, relate to individual body processing, not the drug itself.
Other factors are specific to cannabis use, including:
– Dosage: How much you consume
– Frequency: How often you use cannabis
– Method of consumption: Smoking, dabbing, edibles, or sublingual
– THC potency: Higher potency can extend detection time
Higher doses and more frequent use generally extend THC retention. Cannabis consumed orally may remain in the system slightly longer than smoked cannabis, and stronger cannabis strains, higher in THC, may also stay detectable for a longer period.
How Quickly Do the Effects of Cannabis Set In?
When smoking cannabis, effects appear almost immediately, while ingested cannabis may take 1–3 hours to peak.
The psychoactive component THC produces a “high” with common effects such as:
– Altered senses, including perception of time
– Mood changes
– Difficulty with thinking and problem-solving
– Impaired memory
Other short-term effects can include:
– Anxiety and confusion
– Decreased coordination
– Dry mouth and eyes
– Nausea or lightheadedness
– Trouble focusing
– Increased appetite
– Rapid heart rate
– Restlessness and sleepiness
In rare cases, high doses may lead to hallucinations, delusions, or acute psychosis.
Regular cannabis use may have additional mental and physical effects. While research is ongoing, cannabis use may increase the risk of:
– Cognitive issues like memory loss
– Cardiovascular problems including heart disease and stroke
– Respiratory illnesses such as bronchitis or lung infections
– Mood disorders like depression and anxiety
Cannabis use during pregnancy can negatively impact fetal growth and development.
Duration of Effects
Short-term effects generally taper off within 1–3 hours, but for chronic users, some long-term effects may last days, weeks, or even months. Certain effects may even be permanent.
Bottom Line
The amount of time that cannabis remains in your system following a single use varies greatly depending on individual characteristics such as body fat, metabolism, frequency of use, and mode of intake. Frequent users may maintain traces of THC for weeks, whereas infrequent users may test positive for as little as a few days. Hair tests can disclose usage for up to 90 days, while blood and saliva tests identify more recent use. Urine tests are the most popular and have varying detection durations. The duration that THC and its metabolites are detectable will ultimately depend on a number of factors, including dose, strength, and individual body chemistry.
PEE IN A CUP COMING UP, READ ON..
Cannabis News
Is Kratom Addictive? Understanding Dependence, Risks, and Safe Usage
Published
2 days agoon
November 12, 2024By
admin
Is kratom addictive? Discover the potential for dependence on Kratom, the risks involved with its use, and how to approach its consumption responsibly.
From 2011 to 2017, over 1,800 calls to poison centers involved kratom in the U.S. This significant number highlights the concern regarding kratom addiction.
However, without Food and Drug Administration (FDA) oversight, and due to various consumption methods like teas and capsules, there are significant health risks. Safe use of kratom is now in question due to these issues.
Research debates how dependence develops, outlining signs like loss of control and withdrawal symptoms. These signs are seen in regular kratom users. Ironically, some people switch from drugs like heroin to kratom, looking for a legal alternative.
Understanding Kratom: Origins and Prevalence
Kratom comes from the Mitragyna speciosa tree in Southeast Asia. It can act like a stimulant or like opioids, based on how much you take. People use it in different ways, for a small energy boost or stronger effects at higher doses.
The legal status of kratom in the U.S. is complicated and changing. It’s a hot topic because some worry about its misuse. It’s still legal in several states. This shows how different places handle drug rules. The National Institute on Drug Abuse is looking into its medical benefits. But, the FDA hasn’t approved it for medical use yet. The DEA calls it a “drug of concern,” which means policies might change.
-
From 2011 to 2017, poison control centers in the U.S. got over 1,800 reports about kratom. This shows it’s widely used and might pose health risks.
-
Kratom’s main ingredients bind to opioid receptors very strongly, stronger than morphine even. This fact is key to understanding its effects.
-
As more people use kratom, more are reporting serious health problems. These include liver and heart issues, and tough withdrawal symptoms, particularly in those already sick.
The statistics show mounting worries about kratom in the U.S. As its use grows, it’s becoming more important to health policies and laws. What happens next will depend on further research and legal decisions.
Is Kratom Addictive: Investigating the Substance’s Nature
The question of kratom’s addictiveness focuses on how it affects brain receptors and its long-term health implications. The ongoing debate highlights concerns about dependence and the risk of addiction. Scientists are closely looking at these issues.
How Kratom Works in the Brain
Kratom’s main alkaloids, mitragynine and 7-hydroxymitragynine, bind to the brain’s opioid receptors, similar to painkillers and narcotics. This connection suggests a potential risk of dependence. These alkaloids are key to kratom’s pain relief but also point to possible addiction concerns, especially with frequent, high-dose usage.
Patterns and Consequences of Long-term Use
-
Using kratom often, especially in large doses, can increase the risk of dependence and intense withdrawal symptoms, similar to opioid withdrawal.
-
Although some use it for pain or to improve mood, long-term kratom users might see serious health problems, like liver damage and mental health issues.
-
Withdrawal symptoms, including irritability, nausea, and sleep problems, show kratom’s impact on one’s physical and mental health.
Assessment of Addiction Risks
Studies indicate a significant risk of addiction to kratom, especially with high doses or frequent use. Dependence develops as the body gets used to kratom, leading to tolerance and a need for more to feel its effects. Withdrawal symptoms emphasize this risk, as highlighted by health experts.
Physiological Effects: Kratom’s Impact on the Body
There is a lot of debate about the safety and use of kratom. This herbal extract comes from the Mitragyna speciosa plant. It has drawn attention for its possible harmful effects on the body. The FDA has issued many warnings about kratom, raising safety concerns.
-
Kratom Adverse Effects: Kratom users have reported side effects like nausea, vomiting, and confusion. More serious issues include high blood pressure and liver damage. These problems highlight the risks of using kratom.
-
Herbal Extract Safety: Some kratom products contain heavy metals and pathogens. These can cause severe health issues, including death. This shows the importance of safety in herbal products.
-
FDA Warnings and Regulations: The FDA has linked kratom to over 35 deaths and warns against using it. They point out the lack of medical uses and the risk of addiction.
-
Physiological Impact: Kratom’s effects depend on the dose and the user’s body. Yet, it can lead to dangerous outcomes like liver damage and seizures.
-
Safety Concerns from Authorities: Federal agencies like the DEA are worried about kratom’s safety. Although not a controlled substance, monitoring suggests users should be careful.
Kratom might offer temporary relief for some ailments, but it comes with significant risks. The FDA’s warnings should make people think twice. If considering kratom, it’s crucial to talk to a doctor first. Experts stress the need for safety and caution with herbal extracts.
Conclusion
Kratom’s role in health and regulation is complex, with views and research findings widely varied. Some people use kratom for its claimed health benefits, but it’s a hot topic. Experts advise caution and suggest consulting a doctor before using kratom due to the unclear effects.
Clinical studies using scores like SOWS and COWS haven’t confirmed withdrawal symptoms from kratom. This adds to the debate, especially when some users report withdrawal. This makes kratom a controversial subject among different findings and user experiences.
When it comes to treating opioid addiction, kratom can be both helpful and harmful. Some have used it successfully to fight addiction. Yet, some states have banned it. This highlights the need for regulations and consistent product quality. It also raises questions about kratom’s legal status due to mixed actions by authorities.
The situation shows how complex kratom is in the realm of substance use and law. Without clear evidence supporting either its benefits or risks, it poses a challenge. More research is needed to guide regulations and health advice. For now, anyone thinking of using kratom should be careful, seek medical advice, and keep up with laws and health guidelines.
WHAT IS KRATOM ANYWAY? READ ON…
Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em
I Had Just One Puff
Marijuana firms Eaze, Green Dragon find new life after $10 million capital infusion
Get some rest on Modified Grapes—November’s Leafly HighLight
Is Kratom Addictive? Understanding Dependence, Risks, and Safe Usage
New Rule, December 5: Oregon Cannabis Retailers, Processors and Labor Peace Agreements
The CBD Dog Treat Guide
Trippin’ Golf Balls – Can Magic Mushrooms Help Your Golf Game?
Australian Broadcasting Corp Alleges Military Veterans Have Been Targeted By Medicinal Cannabis Companies Via Social Media & Offered Free “Product”
Medical Marijuana Passed in 106 out of 106 Counties and Cities in What State? A. Florida B. Kentucky C. Ohio D. North Dakota
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
City Of Oakland Issues RFP For Employee Training Programs
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing11 months ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse